에서 이용할 수 있어요!
자세히 알아보기
VBI Vaccines
VBIV
VBIV
상장폐지됨
VBIV 종목은 2024년 8월 7일에 상장 폐지됐어요.
소개: VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
직원 수: 138
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
0%
부정적
0%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요